EVALUATION OF MICROSATELLITE INSTABILITY (MSI) AND HUMAN PAPILLOMAVIRUS (HPV) IN COLORECTAL CANCER
Main Article Content
Abstract
Objective: To determine the prevalence of Human Papillomavirus (HPV) infection in patients with primary colorectal cancer (CRC) and to evaluate its association with microsatellite instability (MSI) status. Subjects and Methods: This cross-sectional study included 98 formalin-fixed, paraffin-embedded (FFPE) samples derived from patients diagnosed with primary colorectal cancer (CRC) at Hanoi Medical University Hospital during 2021-2023. HPV DNA was amplified by PCR method, and MSI status was assessed by immunohistochemistry. Data were processed and statistically analyzed using GraphPad Prism 10 software. Results: Among 98 cases, HPV infection was detected in 35 cases (35.7%). MSI was identified in 18 cases (18.4%), mainly observed in stage I and II tumors without lymph node or distant metastasis (p = 0.01). No significant association was found between HPV infection and age, sex, histopathological classification, or MSI status (p > 0.05). Conclusion: MSI status in CRC does not appear to be significantly influenced by HPV infection. However, the detection of HPV in 35.7% of primary CRC cases in this study suggests that HPV may represent a potential risk factor in colorectal carcinogenesis.
Article Details
Keywords
HPV, colorectal cancer, microsatellite instability.
References
2. Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019;16(12): 713-732. doi:10.1038/ s41575-019-0189-8
3. Murphy N, Moreno V, Hughes DJ, et al. Lifestyle and dietary environmental factors in colorectal cancer susceptibility. Mol Aspects Med. 2019;69:2-9. doi:10.1016/j.mam.2019.06.005
4. Pham DX, Phung AHT, Nguyen HD, et al. Trends in colorectal cancer incidence in Ho Chi Minh City, Vietnam (1996–2015): Joinpoint regression and age–period–cohort analyses. Cancer Epidemiol. 2022;77:102113. doi:10.1016/ j.canep.2022.102113
5. Luu HN, Tran MT, Nguyen MVT, et al. Association between body mass index and colorectal adenomas: Findings from a case-control study in Vietnam. Int J Cancer. 2021;149(11): 1898-1909. doi:10.1002/ijc.33757
6. Yamamoto H, Watanabe Y, Arai H, Umemoto K, Tateishi K, Sunakawa Y. Microsatellite instability: A 2024 update. Cancer Sci. 2024;115(6): 1738-1748. doi:10.1111/cas. 16160
7. Parente P, Grillo F, Vanoli A, et al. The Day-To-Day Practice of MMR and MSI Assessment in Colorectal Adenocarcinoma: What We Know and What We Still Need to Explore. Dig Dis Basel Switz. 2023;41(5): 746-756. doi:10.1159/ 000531003
8. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. The Lancet. 2007;370(9590): 890-907. doi:10.1016/S0140-6736(07) 61416-0
9. Ambrosio MR, Niccolai E, Petrelli F, et al. Immune landscape and oncobiota in HPV-Associated Colorectal Cancer: an explorative study. Clin Exp Med. 2023;23(8):5101-5112. doi:10.1007/s10238-023-01165-3
10. Usman M, Hameed Y, Ahmad M. Does human papillomavirus cause human colorectal cancer? Applying Bradford Hill criteria postulates. Ecancermedicalscience. 2020;14:1107. doi:10. 3332/ecancer.2020.1107